First human trial of Covid-19 vaccine finds it is safe, induces immune response  LivemintView Full coverage on Google News
Covid-19: According to the study of 108 adults, the vaccine produced neutralising antibodies.The Ad5 vectored COVID-19 vaccine used in the trial is the first to be tested in humans, the scientists saidCovid-19: According to the study of 108 adults, the vaccine produced neutralising antibodies.The Ad5 vectored COVID-19 vaccine used in the trial is the first to be tested in humans, the scientists said

First human trial of Covid-19 vaccine finds it is safe, induces immune response

A potential coronavirus vaccine developed by China's CanSino Biologics appeared safe and triggered an immune response in healthy adults. The Ad5-nCoV COVID-19 vaccine is currently in phase 2 clinical trial.A potential coronavirus vaccine developed by China's CanSino Biologics appeared safe and triggered an immune response in healthy adults. The Ad5-nCoV COVID-19 vaccine is currently in phase 2 clinical trial.

The trial demonstrates that a single dose of the new adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine produces virus-specific antibodies and T cells in 14 days, making it a potential candidate for further investigation.The trial demonstrates that a single dose of the new adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine produces virus-specific antibodies and T cells in 14 days, making it a potential candidate for further investigation.

First human trial of COVID-19 vaccine found to be safe and effective - Tech Explorist

“"“You're Neal,” she said. “You're Jennifer!” he answered—Jennifer Haller, the world's very first coronavirus vaccine recipient. Browning was the second. They recognized each other from being interviewed on TV." @brookejarvis https://t.co/4ovvTu4cZK”

nxthompson on Twitter: ""“You're Neal,” she said. “You're Jennifer!” he answered—Jennifer Haller, the world's very first coronavirus vaccine recipient. Browning was the second. They recognized each other from being interviewed on TV." @brookejarvis https://t.co/4ovvTu4cZK… https://t.co/xmlMf79drg"

“The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering.”

Bernie Sanders on Twitter: "The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering."

“Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews”

Evan Davis on Twitter: "Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews"

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

The animal studies have provided new hope that an effective vaccine for humans is possible.The animal studies have provided new hope that an effective vaccine for humans is possible.

Monkeys Protected From COVID-19 With Prototype Vaccines

This week's coronavirus vaccine race news: U.S. bets big on possible vaccine, Chinese entry shows promise, experts caution 'slow is fast.'

Latest on global search for coronavirus vaccine: Three candidates show early promise

Beijing, May 23 The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new reChen said the vaccine is a potential candidate for further investigation The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.

First coronavirus vaccine human trial finds it is safe, induces immune response : The Tribune India

Researchers find that the vaccine was tolerable and immune-producing 28 days after vaccination.Researchers find that the vaccine was tolerable and immune-producing 28 days after vaccination.

China's COVID-19 vaccine shows promise; groups warn about childhood vaccine disruptions | CIDRAP

A potential coronavirus vaccine developed in China appeared safe and able to generate an immune response after an early trial in more than 100 people.The vaccine appeared safe and able to generate an immune response.

Coronavirus vaccine tested in China shows promise after early study in 100 people | Live Science

The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released preliminary data this week, but it was seen as too early for interpreting its vaccine's efficacy.The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released preliminary data this week, but it was seen as too early for interpreting its vaccine's efficacy.

CanSino beats Moderna again, this time to peer-reviewed, published Covid-19 vaccine data - MedCity News

First human trial for adenovirus type-5 vectored vaccine adequate to move into phase II, researchers sayFirst human trial for adenovirus type-5 vectored vaccine adequate to move into phase II, researchers say

COVID-19 Vax Safe, Produced Responses in Healthy Chinese Adults | MedPage Today

Using a series of prototype vaccines—ones used for medical research only and not intended for human use—researchers found that the interventions prevented rhesus macaques from becoming infected by the novel coronavirus. In a related experiment, macaques that tested positive for the virus were protected from re-infection when they encountered it a second time.Using a series of prototype vaccines—ones used for medical research only and not intended for human use—researchers found that the interventions prevented rhesus macaques from becoming infected by the novel coronavirus. In a related experiment, macaques that tested positive for the virus were protected from re-infection when they encountered it a second time.

Studies in monkeys show that coronavirus immunity holds up in vaccine treatments | Popular Science

A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2

First successful human trial of Covid-19 vaccine finds it 'safe for use' - Daily Star

Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good newsResearchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news

Early Coronavirus Immunity Data Fuel Promise for a Vaccine - Scientific American

A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies involved injecting the virus into monkeys, and of those that recovered, they seem to have developed an immunity to the disease.The studies were published on Wednesday, according to Reuters, which [...]A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies [...]

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

An early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early stage trials | TheHill

An early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early stage trials | TheHill

The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published ...

First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal. A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal.

Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.

Early study of Covid-19 vaccine developed in China sees mixed results

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Why%20we%20might%20not%20get%20a%20coronavirus%20vaccine%20%7C%20Coronavirus%20outbreak%20%7C%20The%20GuardianPoliticians have become more cautious about immunisation prospects. They are right to be

Why we might not get a coronavirus vaccine | Coronavirus outbreak | The Guardian

A Chinese-developed COVID-19 adenovirus vector vaccine candidate became the first in the world to disclose complete phase one clinical trial results and declare dual immune response in the recipient on Friday, representing a significant milestone in its results and boost in confidence for current and prospective volunteers in clinical trials.

Chinese COVID-19 vaccine team praised for releasing complete data; early results promising - Global Times

A Chinese drugmaker published a paper detailing promising data on a Phase 1 trial of its own Covid-19 vaccine candidate.A Chinese drugmaker published a paper detailing promising data on a Phase 1 trial of its own Covid-19 vaccine candidate.

Chinese Covid-19 Vaccine Trial Data Are a Good Sign for J&J and AstraZeneca’s Efforts - Barron's

Vaccine goal tailor-made for China's biotech firms - World - Chinadaily.com.cn

Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.

Doubts greet $1.2 billion bet by United States on a coronavirus vaccine by October | Science | AAAS

The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.

CanSino Biologics coronavirus vaccine human results - Business Insider

Bloomberg - Are you a robot?

The Lancet published the phase-1 trial results of a possible COVID-19 vaccine from China. It seems to be safe and effective. But it has to go through more trials before being put on the market.

Chinese COVID-19 vaccine shows promising results - CGTN

Developed by Beijing-based firm, the vaccine shows development of both forms of immunity  Developed by Beijing-based firm, the vaccine shows development of both forms of immunity  

Early human trial of COVID-19 vaccine gives positive results

In one of the new studies, researchers infected nine monkeys with Sars-CoV-2, which causes Covid-19. After they recovered, the team exposed them to the virus again and the animals did not get sick.In one of the new studies, researchers infected nine monkeys with Sars-CoV-2, which causes Covid-19. After they recovered, the team exposed them to the virus again and the animals did not get sick.

Covid-19: Two studies indicate reinfection may not happen - world news - Hindustan Times

Trial was carried out on 108 participants aged 18-60 in WuhanTrial was carried out on 108 participants aged 18-60 in Wuhan

Phase-1 trial: Adenovirus COVID-19 vaccine found safe, induces immune responses - The Hindu

Vaccine developers have four major strategies in their efforts to make a coronavirus vaccine: gene-based, adenovirus vectors, inactivated, and protein subunit. All have pros and cons, both around how they provide protection from a virus and how they’re manufactured.There are other options if they don’t work.

Unproven strategies lead the race for a COVID-19 vaccine - The Verge

The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus -- a "milestone" in the battle to defeat the deadly bug, a new study found.The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus — a “milestone” in the battle to defeat

Coronavirus vaccine gets positive results in first human trial

A LEADING health expert has warned that it will be 'harder to get rid of Covid' than smallpox, as fears grow that it may never be possible to develop a vaccine capable of completely eradicating the deadly disease.A LEADING health expert has warned that it will be "harder to get rid of Covid" than smallpox, as fears grow that it may never be possible to develop a vaccine capable of completely eradicating the deadly disease.

Coronavirus news: Deadly virus may NEVER be eradicated as doubts over vaccines grow | World | News | Express.co.uk

The novel coronavirus has killed at least 335,538 people since the outbreak first emerged in China last December, according to a tally from official sources compiled by AFP at 1900 GMT on Friday.   The novel coronavirus has killed at least 335,538 people since the outbreak first emerged in China last December, according to a tally from official sources compiled by AFP at 1900 GMT on Friday.  

More than 335,000 dead from coronavirus; 5.1 million cases worldwide | ABS-CBN News

A possible vaccine against the strain of coronavirus causing the COVID-19 pandemic has seen early signs of success in China. However, we are "still a long way from a vaccine for all," a Beijing scientist warned.A possible vaccine against the strain of coronavirus causing the COVID-19 pandemic has seen early signs of success in China. However, we are "still a long way from a vaccine for all," a Beijing scientist warned.

Coronavirus vaccine human tests show initial promise | News | DW | 22.05.2020

The first Covid-19 vaccine to be tested in humans has been found to be safe, well-tolerated, and able to generate an immune response against the… The first Covid-19 vaccine to be tested in humans has been found to be safe, well-tolerated, and able to generate an immune response against the…

Coronavirus: Cure hope as first ever human trial of a possible vaccine finds that it 'generates immune response within 28 days' | HeraldScotland

In a matter of months, novel coronavirus has turned the whole world upside downIn a matter of months, novel coronavirus has turned the whole world upside down

Why the vaccine for COVID-19 is still several months away

Access Denied

China, the country where the virus originated has seen first vaccine candidate finish its phase one trial on humans, and the results have been promising. China, the country where the virus originated has seen first vaccine candidate finish its phase one trial on humans, and the results have been promising.